NextCure, Inc.
3 private offerings reported to the SEC on Form D since 2016, $129.9M sold in all. Biotech, MD.
- Form D offerings: 3
- Reported sold: $129.9M
- Newest: Dec 10, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Dec 10, 2025 | $21.5M | $21.5M | NextCure, Inc.Biotech · MD | Not amended | 0001104659-25-119801 |
| Nov 19, 2018 | $93.4M | $93.4M | NextCure, Inc.Biotech · MD | Not amended | 0001567619-18-006604 |
| Jan 11, 2016 | $15.0M | $67.0M | NextCure, Inc.Biotech · MD | Not amended | 0001140361-16-047469 |
SEC Profile
From the company's EDGAR record- Ticker
- NXTC
- Business address
- Baltimore, Md
- Incorporated in
- DE
- SEC industry
- Pharmaceutical Preparations
- All SEC filings
- CIK 1661059 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR